News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Royalty Pharma Plc Cl A
(NQ:
RPRX
)
28.09
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
28.09
Bid (Size)
28.10 (1)
Ask (Size)
30.16 (1)
Prev. Close
28.09
Today's Range
28.09 - 28.09
52wk Range
25.92 - 34.74
Shares Outstanding
388,132,400
Dividend Yield
2.85%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
RPRX stock results show that Royalty Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Royalty Pharma Reports First Quarter 2024 Results
May 09, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Performance
YTD
-0.64%
-0.64%
1 Month
-0.46%
-0.46%
3 Month
-3.30%
-3.30%
6 Month
+3.61%
+3.61%
1 Year
-18.18%
-18.18%
More News
Read More
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
May 09, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
May 02, 2024
Via
Benzinga
NASDAQ:RPRX: good value for what you're paying.
April 24, 2024
Via
Chartmill
Looking Into Royalty Pharma's Recent Short Interest
April 04, 2024
Via
Benzinga
NASDAQ:RPRX is an undervalued gem with solid fundamentals.
March 29, 2024
Via
Chartmill
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
April 19, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Declares Second Quarter 2024 Dividend
April 17, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
3 Pharma Stocks to Sell in April Before They Crash & Burn
April 11, 2024
Via
InvestorPlace
Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You’ve Never Heard Of)
April 09, 2024
Via
InvestorPlace
Royalty Pharma's Earnings: A Preview
February 14, 2024
Via
Benzinga
April’s Hidden Gems: 3 Overlooked Stocks to Freshen Up Your Portfolio
April 09, 2024
Via
InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
March 27, 2024
Via
InvestorPlace
For those who appreciate value investing, NASDAQ:RPRX is a compelling option with its solid fundamentals.
February 29, 2024
Via
Chartmill
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
February 28, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months
February 16, 2024
Via
The Motley Fool
Royalty Pharma Reports Q4 and Full Year 2023 Results
February 15, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
February 08, 2024
Via
InvestorPlace
NASDAQ:RPRX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
February 08, 2024
Via
Chartmill
How Risky Is Royalty Pharma’s Dividend?
February 07, 2024
Via
Talk Markets
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
January 30, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Top Stocks That Just Increased Their Dividends
January 23, 2024
Via
Talk Markets
Royalty Pharma Announces Dividend Increase
January 19, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.